PeptidePedia The community reference

Counterfeit peptide (revision 10)

Old revision·19:56, 23 Feb 2025·StubSorterBot

This is an old revision of this page, as it stood at 19:56, 23 Feb 2025, saved by StubSorterBot with the summary bot: normalise citation format. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Counterfeit peptide
SubstitutionA different, usually cheaper, compound
DilutionThe correct compound with undeclared bulking agent
Misrepresented originCorrect compound, false provenance
Detected byIdentity determination, not purity
Topic infobox · conventions

A counterfeit peptide is material misrepresented as to what it is or where it came from. Three forms are usually distinguished: substitution of a different compound, dilution of the correct compound with an undeclared bulking agent, and misrepresentation of origin where the compound is correct but the stated source is not.[1]

The determination that detects substitution is identity — mass confirmation, and where available sequence confirmation — not purity. A substituted compound analysed alone will return an excellent area percent figure, because it is a pure sample of whatever it actually is.[2]

Dilution is detected by content rather than by purity, for the same reason underfilling is: a bulking agent that does not absorb at the detection wavelength is invisible to a chromatographic purity determination. See Underfilling.

Substitution

[edit]

Substitution replaces the ordered compound with a different one, usually cheaper and often structurally unrelated. Because purity determinations are normalised and identity is frequently not determined, substitution can pass every check a purchaser typically makes.[2]

Identity determination is the remedy and is not expensive relative to the purchase. A mass determination compares the observed molecular mass with the calculated one; agreement to within a few daltons excludes most substitutions outright. It does not exclude an isobaric substitution — a different molecule of the same mass — for which sequence-level confirmation is required.

The confounding case is a peptide of similar mass in the same family. Analogues within the incretin class differ by hundreds of daltons and are readily distinguished; a deletion sequence of the intended peptide differs by a single residue and is a synthesis defect rather than a counterfeit, though the analytical challenge is comparable. See Analytical method validation.

References

  1. ^ PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see Project:Sourcing guidelines).
  2. ^ a b United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.